Biofrontera (B8F) Financial Statements

0 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently CHF17.52M. The company's EPS TTM is $; its P/E ratio is -1.32; Biofrontera is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	€ 13.19M	€ 12.18M	€ 32.25M	€ 25.74M	€ 28.79M
Gross Profit	€ 10.91M	€ 10.12M	€ 25.37M	€ 20.98M	€ 24.87M
Operating Income	€ -1.02M	€ -1.59M	€ 4.78M	€ 1.59M	€ -35.34M
EBITDA	€ -560.00K	€ -301.00K	€ 5.57M	€ 2.34M	€ -12.59M
Net Income	€ -3.96M	€ -4.35M	€ -369.00K	€ -44.17M	€ 37.75M
Balance Sheet
Cash & Short-Term Investments	€ 3.62M	€ 3.28M	€ 3.08M	€ 6.38M	€ 6.91M
Total Assets	€ 20.64M	€ 30.15M	€ 30.73M	€ 32.73M	€ 76.13M
Total Debt	€ 626.00K	€ 765.00K	€ 1.15M	€ 1.50M	€ 3.30M
Net Debt	€ -2.98M	€ -2.36M	€ -1.93M	€ -4.88M	€ -3.61M
Total Liabilities	€ 5.80M	€ 11.30M	€ 10.75M	€ 12.39M	€ 18.70M
Stockholders' Equity	€ 14.90M	€ 18.86M	€ 19.98M	€ 20.34M	€ 57.43M
Cash Flow
Free Cash Flow	€ -4.45M	€ -2.75M	€ -2.83M	€ -4.88M	€ 29.81M
Operating Cash Flow	€ -4.40M	€ -2.54M	€ -1.92M	€ -3.90M	€ 30.44M
Investing Cash Flow	€ 5.33M	€ -210.00K	€ -912.00K	€ -981.00K	€ -42.26M
Financing Cash Flow	€ -452.00K	€ 2.79M	€ -467.00K	€ 4.34M	€ 2.18M

Currency in EUR

Biofrontera Earnings and Revenue History

Income Statement >

Biofrontera Debt to Assets

Balance Sheet >

Biofrontera Cash Flow

Cash Flow >

Biofrontera Forecast EPS vs Actual EPS

Earnings >